About this trial
The goal of this clinical trial is to learn about the effect of communicative interaction on verbal communication in people with amyotrophic lateral sclerosis (ALS) and their caregivers.
The question is, What are the effects of communicative interaction on verbal communication in people with ALS when they interact with their caregivers and does this change over time?
Participants will read words and sentences while they are interacting with their caregivers.
Eligibility criteria
Qualifiers
diagnosis of ALS following the revised EL Escorial criteria
no history of other neurological conditions (e.g., stroke)
no cognitive impairment assessed by Telephone Montreal Cognitive Assessment (mini MoCA)
detectable speech disturbance according to the ALS Functional Rating Scale-Revised (ALSFRS-R)
Disqualifiers
None
Trial design
Treatments tested in this trial
- Structured Communicative Interaction
- Unstructured communicative interaction
Treatment groups
Sponsors and collaborators
Penn State University
Lead sponsor
National Institute on Deafness and Other Communication Disorders (NIDCD)
Collaborator